Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.35 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.35 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18708367 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL18124851 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL26053622 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL26053729 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL20315781 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL23805714 | 0.99 | ATM (0.43) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL25966358 | 0.97 | L3MBTL1 (0.50) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL23805824 | 0.97 | L3MBTL1 (0.49) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL23598390 | 0.97 | L3MBTL1 (0.49) | L3MBTL1ATMKDM4EKMT2AMEN1 | |
| SCHEMBL25965992 | 0.96 | L3MBTL1 (0.49) | L3MBTL1ATMKDM4EKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-05-26 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662196-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, SLCO4C1 | L3MBTL1 2317/4885ATM 2986/4885KDM4E 3377/4885 |
| US-20180134718-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, SLCO4C1 | L3MBTL1 2317/4885ATM 2986/4885KDM4E 3377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.